Michael Francis Miller, the Chief Technology Officer of Quanterix Corporation, has made several significant stock transactions, as detailed in a recent SEC filing. This move underscores Miller's confidence in the company and its future prospects.
Background
Quanterix Corp, classified under the SIC code for Laboratory Analytical Instruments, focuses on advancing healthcare through its proprietary technology. The company is based in Billerica, Massachusetts, and trades under the ticker symbol QTRX. In the recent SEC filings, Miller has reported multiple transactions involving both common stock and restricted stock units.
What the Filing Says
The SEC filing, dated November 17, 2026, reveals that Miller executed multiple transactions on November 15, 2026. He acquired a total of 81 shares of common stock and 81 restricted stock units, among other transactions. The filing notes, "Miller's ownership following these transactions is now 40,883 shares of common stock." This activity reflects his ongoing investment in the company.
Impact
These transactions may influence investor sentiment towards Quanterix Corp, as they indicate a strong commitment from its leadership. Other executives and stakeholders in the laboratory analytical instruments sector may also take note of Miller's actions, potentially prompting similar moves from their own leadership teams.
What's Next
The filing does not say what happens next.
Read Next
Ampco-Pittsburgh issues investor presentation update
Luda Technology Group signs strategic cooperation agreement
MAIA Biotechnology reports strong results in THIO-101 study
Totah Sami Sells 2,899 Shares of Radcom Ltd
Purple Biotech Reports Q3 2026 Results, Updates on IM1240
Adagene Launches Phase 1 Trial for Colorectal Cancer Therapy









